Pursuant to Regulation 33 of SEBI (LODR) Regulations,2015 -Submission of Unaudited Standalone and Consolidated Financial Results along with Limited Review Report for the Quarter and Half Year ended 30th September,2025.

pdf

Kriti Nutrients Ltd.

08 Nov 2025, 08:57PM

77.50

-1.40%

Corp. Action

Kriti Nutrients Ltd - 533210 - Intimation Of Record Date For Payment Of Interim Dividend.

BSE India

Intimation of record date for payment of Interim Dividend

pdf

Kriti Nutrients Ltd.

08 Nov 2025, 08:42PM

77.50

-1.40%

Corp. Action

Kriti Nutrients Ltd - 533210 - Corporate Action-Board approves Dividend

BSE India

Approval and Payment of Interim Dividend of Rs. 3/- (i.e.300%) on the 5,01,03,520 Equity Shares of Re.1/- each for the Financial Year 2025-26.

pdf

Kriti Nutrients Ltd.

08 Nov 2025, 08:17PM

77.50

-1.40%

Board Meeting

Kriti Nutrients Ltd - 533210 - Board Meeting Outcome for Outcome Of The 03/2025-26 Meeting Of …

BSE India

The outcome of the said Board Meeting is as follows: 1. Approval of the Unaudited Standalone and Consolidated Financial Results of the Company for the Quarter ended and half year ended 30th September, 2025; 2. To take on record the Limited Review Report by the Statutory Auditors for the Unaudited Standalone and Consolidated Financial Results of the Company for the Quarter and half year ended on 30th September, 2025; 3. Declaration of Interim dividend @ Rs. 3.00 (300%) per equity share, to celebrate the 3 decades of Kriti Oil Brand, subject to deduction of tax at source, if any, to be paid to those Members whose names appear in the Register of Members of the Company as on Thursday, 13th November, 2025 being the Record Date, for the purpose of payment of dividend. 4. Other Routine Business Agenda.

pdf

Kriti Nutrients Ltd.

02 Nov 2025

77.50

-1.40%

Result

Kriti Nutrients Ltd - 533210 - Board Meeting Intimation for Corp. Ann. U/R 29(1)(A) Of The …

BSE India

Kriti Nutrients Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2025 ,inter alia, to consider and approve 1. Approval of the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended 30th September, 2025; 2. To take on record the Limited Review Report by the Auditors for the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended 30th September, 2025; 3. Approval of the Unaudited Standalone and Consolidated Statement of Assets and Liabilities for the half year ended on 30th September, 2025; 4. Approval of the Unaudited Standalone and Consolidated Statement of Cash Flow for the half year ended on 30thSeptember, 2025; 5. Declaration of a Special Dividend on 33rd Anniversary of KRITI refined oil (interim dividend), if any; and 6. Other general business as may be transacted by the Board.

pdf